Summit Investment Advisors »

X4 Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $34k 7.3k 4.67

More positions owned by Summit Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class C cs (GOOG)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Ishares Tr Etf (IVV)
Alphabet Inc Class A cs (GOOGL)
Vanguard Europe Pacific ETF (VEA)
Tesla Motors (TSLA)
Vanguard Index Fds Etf (VOO)
Ishares Tr Etf (AGG)
Spdr Series Trust Etf (ONEV)

View all positions for Summit Investment Advisors

Top funds holding X4 Pharmaceuticals

Morgan Stanley
FMR
Bain Capital Life Sciences Investors
Perceptive Advisors
Saturn V Capital Management
Empery Asset Management
Deep Track Capital
BlackRock
Kalehua Capital Management
Vanguard Capital Management
Rosalind Advisors
Braidwell
Blackstone Group
Trails Edge Capital Partners
Nantahala Capital Management

View all funds holding X4 Pharmaceuticals